A framework for analyzing cancer mutational signatures is presented in Nature Cancer this week. Developed by researchers from the University of Cambridge, the framework is applied to 3,107 whole genome-sequenced primary cancers of 21 organs and reveals both known signatures and nine previously undescribed rearrangement signatures.